Selected research
Market Outlook & Growth Opportunities
Global Influenza A/B Virus Antigen Detection Kits Market Outlook and Growth Opportunities 2026
Market perspective
The global Influenza A/B Virus Antigen Detection Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Influenza A/B Virus Antigen Detection Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Influenza A/B Virus Antigen Detection Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Influenza A/B Virus Antigen Detection Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Influenza A/B Virus Antigen Detection Kits market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Influenza A/B Virus Antigen Detection Kits market include BD, Abbott, Quidel, Actim, Denka, Roche, Thermo Fisher Scientific, Meridian Bioscience and Sekisui Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Influenza A/B Virus Antigen Detection Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Influenza A/B Virus Antigen Detection Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Influenza A/B Virus Antigen Detection Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Influenza A/B Virus Antigen Detection Kits market size, projected growth trends, production technologies, key applications, and end-use industries.
Influenza A/B Virus Antigen Detection Kits Segment by Company
BD
Abbott
Quidel
Actim
Denka
Roche
Thermo Fisher Scientific
Meridian Bioscience
Sekisui Diagnostics
Princeton BioMeditech
Access Bio
Response Biomedical
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
Daan Gene
Kehua Bio-Engineering
Zhuhai Encode Medical Engineering
Influenza A/B Virus Antigen Detection Kits Segment by Type
Immunochromatography
Colloidal Gold Method
Others
Influenza A/B Virus Antigen Detection Kits Segment by Application
Hospital
Clinics
Home
Others
Influenza A/B Virus Antigen Detection Kits Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Influenza A/B Virus Antigen Detection Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Influenza A/B Virus Antigen Detection Kits market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Influenza A/B Virus Antigen Detection Kits significant trends, drivers, influence factors in global and regions.
6. To analyze Influenza A/B Virus Antigen Detection Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza A/B Virus Antigen Detection Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Influenza A/B Virus Antigen Detection Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza A/B Virus Antigen Detection Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Influenza A/B Virus Antigen Detection Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Influenza A/B Virus Antigen Detection Kits industry.
Chapter 3: Detailed analysis of Influenza A/B Virus Antigen Detection Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Influenza A/B Virus Antigen Detection Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Influenza A/B Virus Antigen Detection Kits in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Immunochromatography
- Colloidal Gold Method
- Others
Applications
- Hospital
- Clinics
- Home
- Others
Companies covered
- BD
- Abbott
- Quidel
- Actim
- Denka
- Roche
- Thermo Fisher Scientific
- Meridian Bioscience
- Sekisui Diagnostics
- Princeton BioMeditech
- Access Bio
- Response Biomedical
- Guangzhou Wondfo Biotech
- Jiangsu Bioperfectus Technologies
- Hangzhou Biotest Biotech
- Wantai BioPharm
- Daan Gene
- Kehua Bio-Engineering
- Zhuhai Encode Medical Engineering
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Influenza A/B Virus Antigen Detection Kits Sales Value (2021-2032)
- 1.2.2 Global Influenza A/B Virus Antigen Detection Kits Sales Volume (2021-2032)
- 1.2.3 Global Influenza A/B Virus Antigen Detection Kits Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Influenza A/B Virus Antigen Detection Kits Market Dynamics
- 2.1 Influenza A/B Virus Antigen Detection Kits Industry Trends
- 2.2 Influenza A/B Virus Antigen Detection Kits Industry Drivers
- 2.3 Influenza A/B Virus Antigen Detection Kits Industry Opportunities and Challenges
- 2.4 Influenza A/B Virus Antigen Detection Kits Industry Restraints
3 Influenza A/B Virus Antigen Detection Kits Market by Company
- 3.1 Global Influenza A/B Virus Antigen Detection Kits Company Revenue Ranking in 2025
- 3.2 Global Influenza A/B Virus Antigen Detection Kits Revenue by Company (2021-2026)
- 3.3 Global Influenza A/B Virus Antigen Detection Kits Sales Volume by Company (2021-2026)
- 3.4 Global Influenza A/B Virus Antigen Detection Kits Average Price by Company (2021-2026)
- 3.5 Global Influenza A/B Virus Antigen Detection Kits Company Ranking (2024-2026)
- 3.6 Global Influenza A/B Virus Antigen Detection Kits Company Manufacturing Base and Headquarters
- 3.7 Global Influenza A/B Virus Antigen Detection Kits Company Product Type and Application
- 3.8 Global Influenza A/B Virus Antigen Detection Kits Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Influenza A/B Virus Antigen Detection Kits Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Influenza A/B Virus Antigen Detection Kits Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Influenza A/B Virus Antigen Detection Kits Market by Type
- 4.1 Influenza A/B Virus Antigen Detection Kits Type Introduction
- 4.1.1 Immunochromatography
- 4.1.2 Colloidal Gold Method
- 4.1.3 Others
- 4.2 Global Influenza A/B Virus Antigen Detection Kits Sales Volume by Type
- 4.2.1 Global Influenza A/B Virus Antigen Detection Kits Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Influenza A/B Virus Antigen Detection Kits Sales Volume by Type (2021-2032)
- 4.2.3 Global Influenza A/B Virus Antigen Detection Kits Sales Volume Share by Type (2021-2032)
- 4.3 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Type
- 4.3.1 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Type (2021-2032)
- 4.3.3 Global Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type (2021-2032)
5 Influenza A/B Virus Antigen Detection Kits Market by Application
- 5.1 Influenza A/B Virus Antigen Detection Kits Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinics
- 5.1.3 Home
- 5.1.4 Others
- 5.2 Global Influenza A/B Virus Antigen Detection Kits Sales Volume by Application
- 5.2.1 Global Influenza A/B Virus Antigen Detection Kits Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Influenza A/B Virus Antigen Detection Kits Sales Volume by Application (2021-2032)
- 5.2.3 Global Influenza A/B Virus Antigen Detection Kits Sales Volume Share by Application (2021-2032)
- 5.3 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Application
- 5.3.1 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Application (2021-2032)
- 5.3.3 Global Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application (2021-2032)
6 Influenza A/B Virus Antigen Detection Kits Regional Sales and Value Analysis
- 6.1 Global Influenza A/B Virus Antigen Detection Kits Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Influenza A/B Virus Antigen Detection Kits Sales by Region (2021-2032)
- 6.2.1 Global Influenza A/B Virus Antigen Detection Kits Sales by Region: 2021-2026
- 6.2.2 Global Influenza A/B Virus Antigen Detection Kits Sales by Region (2027-2032)
- 6.3 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Region (2021-2032)
- 6.4.1 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Region: 2021-2026
- 6.4.2 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Region (2027-2032)
- 6.5 Global Influenza A/B Virus Antigen Detection Kits Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Influenza A/B Virus Antigen Detection Kits Sales Value (2021-2032)
- 6.6.2 North America Influenza A/B Virus Antigen Detection Kits Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Influenza A/B Virus Antigen Detection Kits Sales Value (2021-2032)
- 6.7.2 Europe Influenza A/B Virus Antigen Detection Kits Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Influenza A/B Virus Antigen Detection Kits Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Influenza A/B Virus Antigen Detection Kits Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Influenza A/B Virus Antigen Detection Kits Sales Value (2021-2032)
- 6.9.2 South America Influenza A/B Virus Antigen Detection Kits Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Influenza A/B Virus Antigen Detection Kits Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Influenza A/B Virus Antigen Detection Kits Sales Value Share by Country, 2025 VS 2032
7 Influenza A/B Virus Antigen Detection Kits Country-level Sales and Value Analysis
- 7.1 Global Influenza A/B Virus Antigen Detection Kits Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Influenza A/B Virus Antigen Detection Kits Sales by Country (2021-2032)
- 7.3.1 Global Influenza A/B Virus Antigen Detection Kits Sales by Country (2021-2026)
- 7.3.2 Global Influenza A/B Virus Antigen Detection Kits Sales by Country (2027-2032)
- 7.4 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Country (2021-2032)
- 7.4.1 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Country (2021-2026)
- 7.4.2 Global Influenza A/B Virus Antigen Detection Kits Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.9.2 France Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.16.2 China Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.19.2 India Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Influenza A/B Virus Antigen Detection Kits Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Influenza A/B Virus Antigen Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Influenza A/B Virus Antigen Detection Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 BD
- 8.1.1 BD Company Information
- 8.1.2 BD Business Overview
- 8.1.3 BD Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.1.4 BD Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.1.5 BD Recent Developments
- 8.2 Abbott
- 8.2.1 Abbott Company Information
- 8.2.2 Abbott Business Overview
- 8.2.3 Abbott Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Abbott Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.2.5 Abbott Recent Developments
- 8.3 Quidel
- 8.3.1 Quidel Company Information
- 8.3.2 Quidel Business Overview
- 8.3.3 Quidel Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Quidel Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.3.5 Quidel Recent Developments
- 8.4 Actim
- 8.4.1 Actim Company Information
- 8.4.2 Actim Business Overview
- 8.4.3 Actim Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Actim Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.4.5 Actim Recent Developments
- 8.5 Denka
- 8.5.1 Denka Company Information
- 8.5.2 Denka Business Overview
- 8.5.3 Denka Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Denka Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.5.5 Denka Recent Developments
- 8.6 Roche
- 8.6.1 Roche Company Information
- 8.6.2 Roche Business Overview
- 8.6.3 Roche Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Roche Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.6.5 Roche Recent Developments
- 8.7 Thermo Fisher Scientific
- 8.7.1 Thermo Fisher Scientific Company Information
- 8.7.2 Thermo Fisher Scientific Business Overview
- 8.7.3 Thermo Fisher Scientific Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Thermo Fisher Scientific Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.7.5 Thermo Fisher Scientific Recent Developments
- 8.8 Meridian Bioscience
- 8.8.1 Meridian Bioscience Company Information
- 8.8.2 Meridian Bioscience Business Overview
- 8.8.3 Meridian Bioscience Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Meridian Bioscience Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.8.5 Meridian Bioscience Recent Developments
- 8.9 Sekisui Diagnostics
- 8.9.1 Sekisui Diagnostics Company Information
- 8.9.2 Sekisui Diagnostics Business Overview
- 8.9.3 Sekisui Diagnostics Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Sekisui Diagnostics Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.9.5 Sekisui Diagnostics Recent Developments
- 8.10 Princeton BioMeditech
- 8.10.1 Princeton BioMeditech Company Information
- 8.10.2 Princeton BioMeditech Business Overview
- 8.10.3 Princeton BioMeditech Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Princeton BioMeditech Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.10.5 Princeton BioMeditech Recent Developments
- 8.11 Access Bio
- 8.11.1 Access Bio Company Information
- 8.11.2 Access Bio Business Overview
- 8.11.3 Access Bio Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Access Bio Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.11.5 Access Bio Recent Developments
- 8.12 Response Biomedical
- 8.12.1 Response Biomedical Company Information
- 8.12.2 Response Biomedical Business Overview
- 8.12.3 Response Biomedical Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Response Biomedical Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.12.5 Response Biomedical Recent Developments
- 8.13 Guangzhou Wondfo Biotech
- 8.13.1 Guangzhou Wondfo Biotech Company Information
- 8.13.2 Guangzhou Wondfo Biotech Business Overview
- 8.13.3 Guangzhou Wondfo Biotech Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Guangzhou Wondfo Biotech Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.13.5 Guangzhou Wondfo Biotech Recent Developments
- 8.14 Jiangsu Bioperfectus Technologies
- 8.14.1 Jiangsu Bioperfectus Technologies Company Information
- 8.14.2 Jiangsu Bioperfectus Technologies Business Overview
- 8.14.3 Jiangsu Bioperfectus Technologies Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Jiangsu Bioperfectus Technologies Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.14.5 Jiangsu Bioperfectus Technologies Recent Developments
- 8.15 Hangzhou Biotest Biotech
- 8.15.1 Hangzhou Biotest Biotech Company Information
- 8.15.2 Hangzhou Biotest Biotech Business Overview
- 8.15.3 Hangzhou Biotest Biotech Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Hangzhou Biotest Biotech Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.15.5 Hangzhou Biotest Biotech Recent Developments
- 8.16 Wantai BioPharm
- 8.16.1 Wantai BioPharm Company Information
- 8.16.2 Wantai BioPharm Business Overview
- 8.16.3 Wantai BioPharm Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Wantai BioPharm Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.16.5 Wantai BioPharm Recent Developments
- 8.17 Daan Gene
- 8.17.1 Daan Gene Company Information
- 8.17.2 Daan Gene Business Overview
- 8.17.3 Daan Gene Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Daan Gene Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.17.5 Daan Gene Recent Developments
- 8.18 Kehua Bio-Engineering
- 8.18.1 Kehua Bio-Engineering Company Information
- 8.18.2 Kehua Bio-Engineering Business Overview
- 8.18.3 Kehua Bio-Engineering Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Kehua Bio-Engineering Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.18.5 Kehua Bio-Engineering Recent Developments
- 8.19 Zhuhai Encode Medical Engineering
- 8.19.1 Zhuhai Encode Medical Engineering Company Information
- 8.19.2 Zhuhai Encode Medical Engineering Business Overview
- 8.19.3 Zhuhai Encode Medical Engineering Influenza A/B Virus Antigen Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Zhuhai Encode Medical Engineering Influenza A/B Virus Antigen Detection Kits Product Portfolio
- 8.19.5 Zhuhai Encode Medical Engineering Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Influenza A/B Virus Antigen Detection Kits Value Chain Analysis
- 9.1.1 Influenza A/B Virus Antigen Detection Kits Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Influenza A/B Virus Antigen Detection Kits Sales Mode & Process
- 9.2 Influenza A/B Virus Antigen Detection Kits Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Influenza A/B Virus Antigen Detection Kits Distributors
- 9.2.3 Influenza A/B Virus Antigen Detection Kits Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst